首页> 外文会议>European Haematology Association >Four-year CMV Serologic Profile of Multitransfused Patients (Beta-Thalassaemia Major) in Western Greece
【24h】

Four-year CMV Serologic Profile of Multitransfused Patients (Beta-Thalassaemia Major) in Western Greece

机译:西希腊西部的多元杀菌患者(Beta-Thalassemia专业)的四年CMV血清型剖面

获取原文

摘要

The purpose of this study was to determine the serologic profile of niultitransfused patients (MTP) with beta-thalassaemia major in Western Greece in regard to CMV transmitted by transfusions. Equal blood sera of MTP were studied: 60 for 1998, 60 for 1999, 61 for 2000, 61 for 2001 and 61 in Feb. 2002. Assays were performed by ELISA (IMX-system) and ELFA (Vidas-system). Multitransfused thalassemic patients have a higher incidence of CMV: 63,3% (1998, 1999) and 64% (2000, 2001, 20002) IgG (+) anti-CMV in comparison to the 40,75% observed in the healthy population of the same age range. The incidence of CMV amongst these patients is apparently dependent of age (repeated transfusions). Preventive techniques primarily: leukapheresis and secondly: storing the blood for 48 hrs and screening donors for CMV.
机译:本研究的目的是确定在希腊西部β-Thalassemia主要患者(MTP)的血清曲线剖面,在转灌注传播的CMV。研究了MTP的等于血液血清:1998,60,60,1999,61,2000,61,2001年2月61日,2002年2月61日。通过ELISA(IMX系统)和ELFA(Vidas-System)进行测定。多种子体杀菌患者的CMV发病率较高:63,3%(1998,1999)和64%(2000,2001,20002)IgG(+)抗CMV与在健康人口中观察到的40,75%相同的年龄范围。这些患者中CMV的发生率显然依赖于年龄(重复输血)。预防技术主要是:白蛋白术,其次:将血液储存48小时,并筛选供体进行CMV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号